Skip to main content

Advertisement

SpringerLink
Log in

Das Krankheitsbild Sklerodermie im Begutachtungswesen

Medico-legal assessment of systemic sclerosis

  • Leitthema
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Zusammenfassung

Die Sklerodermie als systemische rheumatologische Erkrankung, stellt selbst in der Gruppe der relativ seltenen Kollagenosen eine Rarität dar. Heterogenes Krankheitsbild und damit oft langwierige Diagnosefindung, sowie das Fehlen einer kausalen oder kurativen Behandlungsstrategie und die gelegentlich düstere Prognose, zeigen dem behandelnden Rheumatologen nach wie vor deutliche Grenzen möglicher Einflussnahme auf das Krankheitsgeschehen auf. Umso mehr kommt der Frage nach krankheitsbedingter Minderung der Erwerbsfähigkeit bei diesen Patienten große Bedeutung zu; und nur bestmögliches Wissen kann die Grundlage einer objektiven Beurteilung schaffen. Dieser Artikel soll das kollegiale Verständnis zwischen Gutachterärzten und Sklerodermiespezialisten fördern.

Abstract

Diagnosis and management of the rare disease systemic sclerosis (scleroderma) is a challenge for the physician, not least due to the possible multitude of organ systems involved. The medico-legal assessment is important for the patient claiming insurance benefits or applying for early retirement due to scleroderma. Both the specialist for sclerosis and the impartial medico-legal assessor have to cooperate and understand the respective partner’s requirements and terminology. Evaluations of individual organ impairments, handicaps and disabilities have to be taken into account when assessing the degree of impairment of occupational activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Genth E, Krieg T (2006) [Systemic sclerosis – diagnosis and classification]. Z Rheumatol 65: 268–274

    Article  PubMed  CAS  Google Scholar 

  2. Legendre C, Allanore Y, Ferrand I, Kahan A (2005) Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 72: 408–411

    Article  PubMed  Google Scholar 

  3. Schady W, Sheard A, Hassell A et al. (1991) Peripheral nerve dysfunction in scleroderma. Q J Med 80(292): 661–675

    PubMed  CAS  Google Scholar 

  4. Rose S, Young MA, Reynolds JC (1998) Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 27: 563–594

    Article  PubMed  CAS  Google Scholar 

  5. Hesselstrand R, Scheja A, Shen GQ et al. (2003) The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 42: 534–540

    Google Scholar 

  6. Steen VD, Powell DL, Medsger TA Jr (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31: 196–203

    Article  PubMed  CAS  Google Scholar 

  7. Buch MH, Denton CP, Furst DE et al. (2007) Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test. Ann Rheum Dis 66: 169–173

    Article  PubMed  CAS  Google Scholar 

  8. Camiciottoli G, Orlandi I, Bartolucci M et al. (2007) Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 131: 672–681

    Article  PubMed  Google Scholar 

  9. McNearney TA, Reveille JD, Fischbach M et al. (2007) Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 57: 318–326

    Article  PubMed  Google Scholar 

  10. Candell-Riera J, Armadans-Gil L, Simeon CP et al. (1996) Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 39: 1138–1145

    Article  PubMed  CAS  Google Scholar 

  11. Foerster J, Kuerth A, Niederstrasser E et al. (2007) A cold-response index for the assessment of Raynaud’s phenomenon. J Dermatol Sci 45: 113–120

    Article  PubMed  Google Scholar 

  12. Steen VD, Medsger TA Jr, Osial TA Jr et al. (1984) Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76: 779–786

    Article  PubMed  CAS  Google Scholar 

  13. Mehlhorn J, Gerlach C, Vetter J (1988) [Occupationally-induced progressive scleroderma and the heart]. Z Gesamte Inn Med 43: 231–234

    PubMed  CAS  Google Scholar 

  14. Nietert PJ, Silver RM (2000) Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 12: 520–526

    Article  PubMed  CAS  Google Scholar 

  15. Haustein UF, Anderegg U (1998) Silica induced scleroderma – clinical and experimental aspects. J Rheumatol 25: 1917–1926

    PubMed  CAS  Google Scholar 

  16. Haustein UF, Herrmann K (1994) Environmental scleroderma. Clin Dermatol 12: 467–473

    Article  PubMed  CAS  Google Scholar 

  17. Haustein UF, Ziegler V, Herrmann K et al. (1990) Silica-induced scleroderma. J Am Acad Dermatol 22: 444–448

    Article  PubMed  CAS  Google Scholar 

  18. Maitre A, Hours M, Bonneterre V et al. (2004) Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 31: 2395–2401

    PubMed  CAS  Google Scholar 

  19. Mayes MD (1999) Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 107 Suppl 5: 743–748

    Article  Google Scholar 

  20. Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40: 1984–1991

    Article  PubMed  CAS  Google Scholar 

  21. Merkel PA (1998) Measurement of functional status, self-assessment, and psychological well-being in scleroderma. Curr Opin Rheumatol 10: 589–594

    Article  PubMed  CAS  Google Scholar 

  22. Sigl T, Ewert T, Stucki G (2004) Patientenzentriertes Assessment der funktionalen Gesundheit bei systemischer Sklerodermie – Wo stehen wir?. Z Rheumatol 63: 463–469

    Article  PubMed  CAS  Google Scholar 

  23. Beretta L, Santaniello A, Lemos A et al. (2007) Validity of the Saint George’s Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxford) 46: 296–301

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Pensionsversicherungsanstalt, Landesstelle Steiermark, Laimburggasse 19/6, 8010, Graz, Österreich

    M. Graninger

Authors
  1. M. Graninger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Graninger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Graninger, M. Das Krankheitsbild Sklerodermie im Begutachtungswesen. Z. Rheumatol. 66, 484–487 (2007). https://doi.org/10.1007/s00393-007-0206-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-007-0206-0

Schlüsselwörter

Keywords

Search

Navigation